NKTX
NkartaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
NKTX vs peer average
48/100
NKTX vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · D 1 · F 6
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ARTV is the first available peer comparator.
Artiva is a closer modality-oriented small-cap cell-therapy comparator than most packet peers, but it is still only a loose read-across because Nkarta is focused on autoimmune CAR-NK execution and upcoming first data.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NKTX
Nkarta
ARTV
Artiva Biotherapeutics
Grade
D
F
Momentum
57
88
Value
41
41
Sentiment
43
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs ARTV
NKTX / ARTV
Grade Position
In line
NKTX vs. peer average (D vs. D)
48/100
Momentum
57
ARTVValue
41
NKTXSentiment
43
NKTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NKTX
ARTV is the first peer returned for this comparison set.